My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: Substance Misuse cancel Blog cancel Delaware cancel New York cancel Maryland cancel

Harm Reduction Policies Can Prevent Overdose Fatalities

Health Policy Update,
State Health Policy,
Opioids,
Overdose Prevention,
Oklahoma,
Alabama,
Connecticut,
Georgia,
Louisiana,
Minnesota,
Nevada,
New Mexico,
Tennessee,
West Virginia,
Wisconsin,
Arkansas,
Delaware,
Illinois,
Maryland,
Massachusetts,
Missouri,
Rhode Island,
Washington,
New York,
California,
Vermont,
JoAnne McClure

Adopting a public health approach to substance use by implementing harm reduction policies across all levels of government can help communities address the overdose crisis. This post analyzes e

ASTHO’s 2024 Legislative Session Update: Part One

Data Modernization,
Arizona,
Health Policy Update,
State Health Policy,
Health Equity,
Environmental Health,
New Hampshire,
Oklahoma,
Maine,
Florida,
Colorado,
Tennessee,
Virginia,
Wisconsin,
California,
New Jersey,
Missouri,
Maryland,
New York,
Georgia,
Delaware,
New Mexico,
Hawaii,
Overdose Prevention,
STIs,
Infant and Child Health,
Lillian Colasurdo,
Maggie Davis,
Lana McKinney,
JoAnne McClure

ASTHO’s 2024 Legislative Session Update: Part One legislative session, state policy, data collection, domestic violence, health information exchange, data privacy, substance misuse, overdose ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

State Health Policy,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, ...